Haydar Witwit

12PUBLICATIONS
21CO-AUTHORS
Medical infection agents (incl. prions)Human impacts of climate change and human adaptationNgā kura kaupapa Māori (Māori primary education)Gene and molecular therapyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 01, 2026
Sirtuin 1 Is Required for Optimal Mammarenavirus Multiplication.

|May 27, 2026
Clinical Characteristics, Risk Factors, and Predictors of Fatal Outcomes and Prolonged Hospitalization of Crimean-Congo Hemorrhagic Fever Cases in Basrah, Iraq.

|Feb 27, 2026
Prolyl tRNA Synthetase Is Required for Mammarenavirus Multiplication.

Haydar Witwit, Pablo Ibanez, Ruifeng Zhou

|Jan 28, 2026
Screening of the Pandemic Response Box Library Identified CRM1/XPO1 as an Anti-Mammarenavirus Druggable Target.

Chukwudi A Ofodile, Beatrice Cubitt, Ngozi Onyemelukwe

|Dec 15, 2025
Pandemic Response Box Screening Identified CRM1/XPO1 as an Anti-Mammarenavirus Druggable Target.

Chukwudi A Ofodile, Beatrice Cubitt, Ngozi Onyemelukwe

|Jun 16, 2025
Mammarenavirus Z Protein Myristoylation and Oligomerization Are Not Required for Its Dose-Dependent Inhibitory Effect on vRNP Activity.

Haydar Witwit, Juan C de la Torre

Pageof 2

Frequent Collaborators

9 joint publications

Juan Carlos de la Torre

7 joint publications

Beatrice Cubitt

6 joint publications

Roaa Khafaji

6 joint publications

Luis Martinez-Sobrido